1747793

Source:http://linkedlifedata.com/resource/pubmed/id/1747793

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018717, umls-concept:C0376541, umls-concept:C0596545, umls-concept:C0683887
pubmed:issue	6
pubmed:dateCreated	1992-1-22
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8307154
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:issn	0735-7907
pubmed:author	pubmed-author:ChuldzinskiPP, pubmed-author:CosterJ MJM, pubmed-author:GianfrancescoFF
pubmed:issnType	Print
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	675-81
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:1747793-Biotechnology, pubmed-meshheading:1747793-Costs and Cost Analysis, pubmed-meshheading:1747793-Erythropoietin, pubmed-meshheading:1747793-Hematopoiesis, pubmed-meshheading:1747793-Humans, pubmed-meshheading:1747793-Kidney Failure, Chronic, pubmed-meshheading:1747793-Medicare, pubmed-meshheading:1747793-Recombinant Proteins, pubmed-meshheading:1747793-Renal Dialysis, pubmed-meshheading:1747793-United States
pubmed:year	1991
pubmed:articleTitle	Paying for expensive new technologies: Medicare's experiences with recombinant erythropoietin.
pubmed:affiliation	U.S. Senate, Special Committee on Aging, Washington, D.C. 20510.
pubmed:publicationType	Journal Article